Emilie Perez is a Quality Assessor at famhp, with experience in regulatory affairs, research, and data analysis in biochemistry and molecular biology. They have a strong educational background with a PhD in Biochemistry, Molecular and Cellular Biology, and Bioinformatics. Emilie's work includes assessing biological and chemical drug products, conducting research on energy metabolism in algae, and analyzing miRNA's role in tumor angiogenesis. Their skills include bioinformatics analysis, scientific writing, data presentation, and cell culture techniques.
FAMHP - Federal Agency for Medicines and Health Products
The Federal Agency for Medicines and Health Products (FAMHP) is the Belgian competent authority in charge of ensuring the quality, safety and efficacy of medicines and health products (medical devices and accessories, raw materials, blood and blood products of human origin, human tissue material), for human and veterinary use, in clinical development and on the market. The famhp works together with the academic world, the pharmaceutical industry and the other industries concerned, healthcare professionals, other national, European and worldwide authorities, as well as policy makers, in order to provide everybody with the necessary medicines and health products and to help patients and citizens to use them correctly. The famhp has grown since its creation from an organization with a few dozen employees to an agency that has more than 500 employees which are mostly scientifically trained. The agency consists out of five entities: three Directorates-General, DG PRE authorisation, DG POST authorisation and DG INSPECTION, the support services and the CEO Services.